AJG vs FGEN · P/E 33, rev $8.76B vs rev $29.6M
Arthur J Gallagher & Co (AJG) versus FibroGen Inc (FGEN) — a side-by-side from cached financials, not a winner call.
Arthur J Gallagher & Co (AJG) is a insurance brokers company listed on US.
FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
Latest reported AJG revenue for 2026-06-30 was $8.76B. Net income was $1.15B. Revenue was up 84.1% from 2026-03-31 to 2026-06-30. AJG currently screens at market cap $52.03B and trailing P/E 32.8.
Latest reported FGEN revenue for 2024-12-31 was $29.6M. Net income was -$47.6M. Revenue was down 36.7% from 2023-12-31 to 2024-12-31. FGEN currently screens at market cap $39.3M.
AJG currently screens at market cap $52.03B and trailing P/E 32.8. FGEN currently screens at market cap $39.3M.
Not investment advice. Open the AJG and FGEN stock pages for the full models.
Not investment advice.